{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:44:35Z","timestamp":1790718275917,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3749,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1523-1755.2005.00495.x","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T17:36:20Z","timestamp":1123781780000},"page":"1032-1040","source":"Crossref","is-referenced-by-count":13,"title":["Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease"],"prefix":"10.1016","volume":"68","author":[{"given":"Jens","family":"Stahlschmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Varley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Toogood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Southgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0010","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1016\/S0021-9258(17)36889-8","article-title":"Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins","volume":"269","author":"Wu","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1083\/jcb.151.5.961","article-title":"Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux","volume":"151","author":"Hu","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0020","doi-asserted-by":"crossref","first-page":"F1200","DOI":"10.1152\/ajprenal.00043.2002","article-title":"Role of membrane proteins in permeability barrier function: Uroplakin ablation elevates urothelial permeability","volume":"283","author":"Hu","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0025","first-page":"583","article-title":"Normal human urothelial cells in vitro: Proliferation and induction of stratification","volume":"71","author":"Southgate","year":"1994","journal-title":"Lab Invest"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0030","series-title":"Culture of Epithelial Cells","first-page":"381","article-title":"Culture of human urothelium","author":"Southgate","year":"2002"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0035","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0002-9440(10)63737-6","article-title":"Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells","volume":"164","author":"Varley","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0040","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1242\/jcs.01042","article-title":"Role of PPAR {gamma} and EGFR signalling in the urothelial terminal differentiation programme","volume":"117","author":"Varley","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0300-9084(93)90084-6","article-title":"The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor","volume":"75","author":"Issemann","year":"1993","journal-title":"Biochimie"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.neo.7900050","article-title":"Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in human transitional bladder cancer and its role in inducing cell death","volume":"1","author":"Guan","year":"1999","journal-title":"Neoplasia"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jcp.10099","article-title":"PPAR gamma ligands suppress proliferation of human urothelial basal cells in vitro","volume":"191","author":"Kawakami","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0002-9440(10)65577-0","article-title":"Differential expression of the peroxisome proliferator-activated receptor gamma (PPAR gamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse","volume":"153","author":"Jain","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)61730-0","article-title":"Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells","volume":"159","author":"Nakashiro","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0075","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1016\/S0021-9258(18)37435-0","article-title":"Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine","volume":"263","author":"Hirata","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0080","series-title":"Histology for Pathologists","first-page":"835","article-title":"Urinary bladder, ureter, and renal pelvis","author":"Reuter","year":"1997"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1349-7006.2002.tb01287.x","article-title":"High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma","volume":"93","author":"Kageyama","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0090","first-page":"2900","article-title":"Human uroplakin Ib in ocular surface epithelium","volume":"41","author":"Adachi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0095","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1006\/bbrc.1996.0832","article-title":"Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa","volume":"222","author":"Mansen","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-0142(19910115)67:2<421::AID-CNCR2820670217>3.0.CO;2-Q","article-title":"Ki-67 immunostaining in human breast tumors and its relationship to prognosis","volume":"67","author":"Wintzer","year":"1991","journal-title":"Cancer"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0105","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0002-9440(10)65709-4","article-title":"Uroplakin gene expression by normal and neoplastic human urothelium","volume":"153","author":"Lobban","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0110","first-page":"657","article-title":"Cytokeratin expression patterns in normal and malignant urothelium: A review of the biological and diagnostic implications","volume":"14","author":"Southgate","year":"1999","journal-title":"Histol Histopathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0120","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/jpet.103.063438","article-title":"The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines","volume":"309","author":"Strakova","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ijc.11447","article-title":"15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway","volume":"107","author":"Chen","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-4827(03)00263-5","article-title":"Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma\/retinoid X receptor alpha pathway","volume":"289","author":"Tsujie","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1252","article-title":"Uroplakin gene expression in normal human tissues and locally advanced bladder cancer","volume":"199","author":"Olsburgh","year":"2003","journal-title":"J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0140","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1091\/mbc.e02-04-0211","article-title":"Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum","volume":"13","author":"Tu","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-4781(02)00304-4","article-title":"Human uroplakin lb gene structure and promoter analysis","volume":"1576","author":"Olsburgh","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0150","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0703149","article-title":"Peroxisome proliferator-activated receptors in the cardiovascular system","volume":"129","author":"Bishop-bailey","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/clinchem\/47.4.768","article-title":"Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine","volume":"47","author":"Thevenon","year":"2001","journal-title":"Clin Chem"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0170","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1074\/jbc.273.12.6689","article-title":"Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter \u201cPGT.\u201d","volume":"273","author":"Chan","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0898-6568(01)00281-9","article-title":"Natural ligands of PPAR gamma: Are prostaglandin J(2) derivatives really playing the part?","volume":"14","author":"Nosjean","year":"2002","journal-title":"Cell Signal"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-6980(02)00134-X","article-title":"Prostaglandin D2 synthase enzymes and PPAR gamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues","volume":"70","author":"Jowsey","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1442-2042.2001.00372.x","article-title":"Transitional cell carcinoma of the renal pelvis in a long-term hemodialysis patient with autosomal dominant polycystic kidney","volume":"8","author":"Miwa","year":"2001","journal-title":"Int J Urol"},{"key":"10.1111\/j.1523-1755.2005.00495.x_bb0190","first-page":"761","article-title":"Bladder cancer in patients undergoing haemodialysis","volume":"71","author":"Morey","year":"1993","journal-title":"Br J Urol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815509307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815509307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T12:15:20Z","timestamp":1648469720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815509307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0085253815509307"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00495.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}